Nanotechnology Applications in Nanomedicine: Recent Advances and Prospects
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Nanochemistry".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 5608
Special Issue Editors
Interests: nanomedicine; nano systems; nanomaterials; nano drugs; drug delivery
Special Issue Information
Dear Colleagues,
Nanomedicine, an offshoot of nanotechnology, is defined as the “science that uses nanomaterials to the development of diagnosis, treatment and prevention of specific medical application.” Nanomedicine is one of the most rapidly growing fields of translational medicine, because it offers great opportunities to promote innovations in numerous medical fields, including controlled drug delivery, biomarkers, molecular imaging, biosensing, and so on. Notably, the contributions of nanomedicine are still growing in a more spectacular way, along with the development of nanotechnology. This Special Issue, "Nanotechnology Applications in Nanomedicine: Recent Advances and Prospects", aims to collect and disseminate some of the most significant and recent contributions in the field of nanomedicine.
We welcome the submission of original research articles, short communications and review articles that cover, but are not limited to, the following topics:
- Functionalized nanosystems for drug delivery.
- Synthesis, pharmacodynamics and pharmacokinetics of nanodrugs.
- Nanomaterials for imaging, biosensing and disease diagnosis.
- Nanomedical devices for regenerative medicine.
- Bioavailability and toxicology of nanomaterials.
Dr. Haijun Shen
Dr. Jin Li
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Liposomes, Dendrimers, and Micelles: Nanoplatforms Revolutionizing Ophthalmic Treatments
Authors: Kevin Yang Wu; Simon D. Tran
Affiliation: Division of Ophthalmology, Department of Surgery, University of Sherbrooke, Sherbrooke, QC J1G 2E8, Canada
Abstract: The eye's complex anatomical structures present formidable barriers to effective drug delivery across a range of ocular diseases, from anterior to posterior segment pathologies. Emerging as a promising
solution to these challenges, nanotechnology-based platforms—namely liposomes, dendrimers, and micelles—have shown the potential to revolutionize ophthalmic therapeutics. These nanocarriers enhance drug bioavailability, increase residence time in targeted ocular tissues, and offer precise, localized delivery, minimizing systemic side effects. Liposomes are versatile carriers capable of encapsulating diverse pharmacological agents, lending utility across a spectrum of ocular conditions. Dendrimers allow for highly targeted drug delivery, particularly useful in posterior segment diseases like retinal degenerations. Micelles offer core-shell architectures optimal for drug loading and sustained release. This review, encompassing literature from 2017 to 2023, offers a comprehensive examination of these nanocarriers, elucidating their impact in transforming the treatment landscape for a broad array of ocular diseases. It underscores the necessity for ongoing research to realize their full clinical potential.
